Showing results (731-740 of 774) with videos related to

Sort By:
Pageof 78
The Journal of Clinical Investigation|May 5, 2010
PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndromeInga Ebermann, Jennifer B Phillips, Max C Liebau, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|December 19, 2017
Optical Coherence Tomography in Patients With the Subretinal Implant Retina Implant Alpha IMSLaura Kuehlewein, Veronique Kitiratschky, Mariya Gosheva, et al.
Investigative Ophthalmology & Visual Science|March 3, 2026
Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt DiseaseFolahan Ibukun, Rupert W Strauss, Zainab Rustam, et al.
American Journal of Ophthalmology|October 25, 2021
Longitudinal Changes in Scotopic and Mesopic Macular Function as Assessed with Microperimetry in Patients With Stargardt Disease: SMART Study Report No. 2Xiangrong Kong, Mohamed Ibrahim-Ahmed, Millena G Bittencourt, et al.
Human Genetics|June 27, 2003
Novel types of mutation in the choroideremia ( CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exonJosé A J M van den Hurk, Dorien J R van de Pol, Bernd Wissinger, et al.
Ophthalmic Research|July 14, 2024
The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18)Rupert Wolfgang Strauss, Lang Lang, Alexander Ho, et al.
Frontiers in Neuroscience|September 8, 2017
Interim Results of a Multicenter Trial with the New Electronic Subretinal Implant Alpha AMS in 15 Patients Blind from Inherited Retinal DegenerationsKatarina Stingl, Ruth Schippert, Karl U Bartz-Schmidt, et al.
Ophthalmic Research|June 26, 2018
Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1)Rupert W Strauss, Xiangrong Kong, Millena G Bittencourt, et al.
JAMA Ophthalmology|August 2, 2019
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11Rupert W Strauss, Xiangrong Kong, Alexander Ho, et al.
The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.
Pageof 78